Partner-Ricolnt – Pioneer in the International Pharmaceutical Market

Rico International is focusing on introducing Japanese pharmaceutical products into China.

Expired patent medicines

Although Japan is a major country in terms of patented pharmaceuticals, it also has many generic drugs. The introduction of specialized generic products can serve as a valuable complement to the Chinese market.

Patented medicine

Introduce new patented drugs to fill gaps in the Chinese market and narrow the gap between China and advanced global standards.

Joint development

Early involvement in Japanese product development; participation in international multi-center studies to ensure that new products are launched simultaneously in China and around the world.

Early development buyout

Japan has numerous projects under development that require external funding. China can leverage its financial strengths to acquire these projects and obtain patent rights.

Maintain good communication and cooperation with Japan's PMDA.

The company has become a strategic partner with more than 50 Japanese pharmaceutical companies.

Domestic partners

PARTNERS